Aug 9, 2026 | Uncategorized
JAMA Intern Med. 2026 Aug 10. doi: 10.1001/jamainternmed.2026.3788. Online ahead of print.NO ABSTRACTPMID:42574008 | DOI:10.1001/jamainternmed.2026.3788
Aug 5, 2026 | Uncategorized
Psychiatr Serv. 2026 Aug 6. doi: 10.1176/appi.ps.20250157. Online ahead of print.ABSTRACTOBJECTIVE: The COVID-19 pandemic exacerbated health disparities and increased alcohol use and its health consequences. Although prepandemic research identified racial and ethnic...
Jul 29, 2026 | Uncategorized
Am J Prev Med. 2026 Jul 30:108537. doi: 10.1016/j.amepre.2026.108537. Online ahead of print.ABSTRACTINTRODUCTION: A 2019 Medicare opioid safety policy limited initial opioid duration to 7 days and long-term daily dosage to 90 morphine milligram equivalence (MME)....
Jul 28, 2026 | Uncategorized
J Pain. 2026 Jul 29:106313. doi: 10.1016/j.jpain.2026.106313. Online ahead of print.ABSTRACTThe aims of this study were to characterize symptom clusters and examine the influence of social determinants of health (SDOH) on symptom cluster membership among people...
Jul 15, 2026 | Uncategorized
Hosp Pediatr. 2026 Jul 17:e2025009094. doi: 10.1542/hpeds.2025-009094. Online ahead of print.ABSTRACTBACKGROUND: Illicitly manufactured fentanyl (IMF) is the predominant opioid in the US drug supply and is a major contributor to morbidity and mortality during...
Jul 13, 2026 | Uncategorized
JAMA Netw Open. 2026 Jul 1;9(7):e2623280. doi: 10.1001/jamanetworkopen.2026.23280.ABSTRACTIMPORTANCE: Buprenorphine-naloxone and extended-release (XR) naltrexone are both efficacious medications for opioid use disorder that reduce unregulated opioid use and improve...
